MRI Contrast Agents Market size was valued at USD 3.25 Billion in 2024 and is projected to reach USD 5.45 Billion by 2033, exhibiting a CAGR of 6.2% from 2026 to 2033.
Start
South Korea's MRI Contrast Agents Market is undergoing significant transformation, driven by technological advancements, regulatory changes, and evolving industry requirements. In 2023, the market was valued at USD 47.5 million and is projected to reach USD 82.4 million by 2030, growing at a CAGR of 8.2%.
Market Segmentation:
Paramagnetic Agents: Dominating the market with an 87.79% revenue share in 2023, these agents are expected to continue their growth trajectory due to their efficacy in enhancing MRI images.
Superparamagnetic Agents: While currently holding a smaller market share, these agents are gaining attention for their potential in specialized imaging applications.
Industry Demand:
Hospitals: As primary end-users, hospitals require high-quality contrast agents for accurate diagnostics. The demand is particularly high for agents that offer clear imaging for complex cases.
Imaging Centers: These centers are increasingly adopting advanced MRI technologies, necessitating contrast agents that are both effective and safe for a wide range of patients.
Regulatory Landscape:
In 2018, the South Korean Ministry of Food and Drug Safety (MFDS) banned 13 linear gadolinium-based contrast agents due to safety concerns.
This regulatory shift has prompted a move towards macrocyclic agents, which are considered safer and more stable.
Research and Development:
South Korean researchers are actively exploring the genetic factors influencing patient responses to MRI contrast agents, aiming to develop personalized and safer imaging solutions.
These efforts are expected to lead to the establishment of a registry for hypersensitivity reactions, enhancing patient safety and treatment outcomes.
In conclusion, the MRI Contrast Agents Market in South Korea is poised for substantial growth, driven by technological innovation, regulatory reforms, and increasing demand from healthcare institutions. Stakeholders are focusing on developing safer, more effective contrast agents to meet the evolving needs of the medical imaging industry.
Get an In-Depth Research Analysis of the South Korea MRI Contrast Agents Market Size And Forecast [2025-2032]
Â
Bayer
Bracco Imaging
Guerbet Group
Hengrui Medicine
Lantheus
YRPG
BeiLu Pharma
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the South Korea MRI Contrast Agents Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the South Korea MRI Contrast Agents Market
Gadolinium-based Contrast Agents
Iron-based Contrast Agents
Perfluorocarbon-based Contrast Agents
Manganese-based Contrast Agents
New and Emerging Agents
Neuroimaging
Cardiovascular Imaging
Oncology Imaging
Musculoskeletal Imaging
Abdominopelvic Imaging
Intravenous Administration
Intra-arterial Administration
Oral Administration
Rectal Administration
Intrathecal Administration
Hospitals
Diagnostic Imaging Centers
Academic Institutions
Research Laboratories
Outpatient Surgical Centers
Ready-to-use Solutions
Lyophilized Powder
Injectable Formulations
Oral Solutions
Novel Formulations (e.g., Nanoparticles)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
For More Information or Query, Visit @ South Korea MRI Contrast Agents Market Research Analysis
1. Introduction of the South Korea MRI Contrast Agents Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. South Korea MRI Contrast Agents Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. South Korea MRI Contrast Agents Market, By Type
6. South Korea MRI Contrast Agents Market, By Application
7. South Korea MRI Contrast Agents Market, By Geography
Asia-Pacific
China
Japan
Korea
India
Australia
Indonesia
Thailand
Philippines
Malaysia and Vietnam
8. South Korea MRI Contrast Agents Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/